Records containing: Neurofibromatosis Type 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; Hydrogen Sulfate in Children With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)
-
CLINICAL_TRIALS study record update · 2026-04-24Variation in Gene Expression in Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2026-04-23Familial Investigations of Childhood Cancer Predisposition
-
CLINICAL_TRIALS study record update · 2026-04-16Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Egy)
-
CLINICAL_TRIALS study record update · 2026-04-14Natural History and Biology of Dermal Neurofibromas in Neurofibromatosis Type 1
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
-
CLINICAL_TRIALS study record update · 2026-04-09Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
-
CLINICAL_TRIALS study record update · 2026-04-09A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
-
CLINICAL_TRIALS study record update · 2026-04-02An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)
-
CLINICAL_TRIALS study record update · 2026-03-20Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2026-03-20A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2026-03-12Post-Authorisation Safety Study of Paediatric Patients Initiating Selumetinib: A Multiple-Country Prospective Cohort Study.
-
CLINICAL_TRIALS study record update · 2026-02-23A Phase I, Single-Arm, Sequential Study to Evaluate the Effect of Food on the Gastrointestinal Tolerability and Pharmacokinetics of Selumetinib After Multiple Doses in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas
-
CLINICAL_TRIALS study record update · 2026-02-12National Cohort for Evaluation of the Burden of Rare Skin Diseases
-
CLINICAL_TRIALS study record update · 2026-01-09Observational Trial of Liquid Biopsy for Malignant Peripheral Nerve Sheath Tumor (MPNST) Among Participants With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2025-10-14Natural History Study of Cutaneous Neurofibromas in People With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2025-09-12Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis
-
CLINICAL_TRIALS study record update · 2025-09-09Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
-
CLINICAL_TRIALS study record update · 2025-09-02Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden
-
CLINICAL_TRIALS study record update · 2025-07-24Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
-
CLINICAL_TRIALS study record update · 2025-06-24Neurobiology and Treatment of Reading Disability in NF1
-
CLINICAL_TRIALS study record update · 2025-05-14A Phase I/II, Single-Arm, Open Label Study to Evaluate the Pharmacokinetics, Safety/Tolerability and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With Neurofibromatosis Type 1 (NF1) Related Symptomatic, Inoperable Plexiform Neurofibromas (PN) (SPRINKLE)
-
CLINICAL_TRIALS study record update · 2025-05-02A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
-
CLINICAL_TRIALS study record update · 2025-04-04US Selumetinib Registry
-
CLINICAL_TRIALS study record update · 2024-12-06MicroRNAs as Disease Markers for Central Nervous System Tumors in Patients With Neurofibromatosis Type 1